¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå ¼ºÀå ¹× µ¿Çâ:
Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼¿¡ µû¸£¸é, ¼¼°è º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö ¿¬Æò±Õ 5.0%ÀÇ ¼ºÀå·ü·Î 34¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Ãæ¼ö¿°Àº Àü ¼¼°è Àα¸ÀÇ ¾à 7.0%¿¡¼ 10.0%°¡ ¾Î°í ÀÖ´Â ÈçÇÑ Áúº´À¸·Î, 2024³â 7¿ù European Journal of Medical &Health Sciences¿¡ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é ±Þ¼º ¸ÍÀå¿°(AA)Àº ¸Å³â ¾à 1¾ï 7,700¸¸ °ÇÀÇ ±Þ¼º º¹ÅëÀ¸·Î ÀÀ±Þ½Ç¿¡ ³»¿øÇÏ´Â ¼ºÀΰú ¼Ò¾ÆÀÇ ±Þ¼º º¹ÅëÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ¿¬°£ ¾à 1,770¸¸ °ÇÀÇ ±Þ¼º º¹ÅëÀÌ ¹ß»ýÇÕ´Ï´Ù. ¸ÍÀå¿°ÀÇ Æò»ý À§Çèµµ´Â 7.0%¿¡¼ 8.0%·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº À¯º´·üÀº È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Å« ¼ö¿ä¸¦ ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÁúȯÀº ´Ù¾çÇÑ ¿¬·ÉÃþ¿¡ ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ ÃÖ¼Òħ½À ¼ö¼ú ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ ±¤¹üÀ§ÇÑ ÀÇ·á ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¥ ÀÖ¾î ½ÃÀåÀÇ ¿ªÇÒ È®´ë°¡ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
º¹°°æ ¼ö¼ú ºÐ¾ß´Â ³î¶ó¿î ¹ßÀüÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀÇ ¸Å¿ì Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ º¹°°æ Ä«¸Þ¶ó, °³¼±µÈ ¿µ»ó ½Ã½ºÅÛ, ·Îº¿ º¸Á¶ ¼ö¼ú Ç÷§Æû°ú °°Àº ±â¼ú Çõ½ÅÀº ¼ö¼úÀÇ Á¤È®¼º°ú °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î, ´ÙºóÄ¡ ¼ö¼ú ½Ã½ºÅÛ°ú °°Àº ·Îº¿ ½Ã½ºÅÛÀÇ ÅëÇÕÀº ¼ÕÀçÁÖ¿Í ÅëÁ¦·ÂÀ» Çâ»ó½ÃÄÑ ¼ö¼ú °á°ú¸¦ °³¼±Çϰí ȸº¹ ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü º¹°°æ µµ±¸¿Í ¿¡³ÊÁö ÀåºñÀÇ °³¹ß·Î ¼ö¼úÀÇ È¿À²¼º°ú ȯÀÚÀÇ ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾î º¹°°æ ¸ÍÀå ÀýÁ¦¼úÀÌ ¸¹Àº ¿Ü°ú ÀÇ»çµé¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå È®´ë¿¡´Â Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À¯·´ÀǾàǰû(EMA)°ú ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú °°Àº ±ÔÁ¦ ±â°üÀº ¾ö°ÝÇÑ ½ÂÀÎ ÀýÂ÷¸¦ ÅëÇØ º¹°°æ ±â±âÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÕ´Ï´Ù. »õ·Î¿î ±â¼úÀÇ ½ÂÀÎÀº ±â¼ú Çõ½Å°ú ½ÃÀå ÁøÀÔÀ» ÃËÁøÇϰí ÀÇ·áÁøÀÌ º¹°°æ ¼ö¼úÀÇ ÃֽйßÀüÀ» ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ±â°üÀº ¶ÇÇÑ »õ·Î¿î ±â±âÀÇ ½ÂÀÎ ÀýÂ÷¸¦ °£¼ÒÈÇÏ°í ½ÃÀå Ãâ½Ã¸¦ ÃËÁøÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.
º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Á¦Ç°º°·Î´Â º¹°°æ ºÎ¹®ÀÌ 2023³â 39.7%·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ´Â ÃÖ¼Òħ½À ¼ö¼úÀÇ Ã¤Åà Áõ°¡, º¹°°æ ±â¼ú ¹ßÀü, ±âÁ¸ °³º¹ ¼ö¼úº¸´Ù º¹°°æ ¸ÍÀå ÀýÁ¦¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
- ±â¼úº°·Î´Â ¸ÖƼÆ÷Æ® º¹°°æ ºÎ¹®ÀÌ 2023³â 43.6%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ 2023³â 61.4%ÀÇ »ó´çÇÑ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ´Â ¸¹Àº ȯÀÚ ¼ö, °í±Þ ÀÎÇÁ¶ó, ¼÷·ÃµÈ ¿Ü°ú ÀÇ»çÀÇ °¡¿ë¼º ¹× º´¿øÀÌ Á¦°øÇÏ´Â Á¾ÇÕÀûÀÎ Ä¡·á·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óºÎ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : Á¦Ç° ´ë½Ãº¸µå
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå, Á¦Ç°º°, ¸ÅÃ⺰
- ÀÇ·á¿ë º¹°°æ ·Îº¿
- º¹°°æ
- ¼öµ¿ ±â±¸
- ÈíÀÔ±â¿Í ºÎ¼Óǰ
Á¦5Àå º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ±â¼ú ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ±â¼ú ´ë½Ãº¸µå
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ±â¼ú º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ±â¼úº°, ¸ÅÃ⺰
- ½Ì±Û Æ÷Æ® º¹°°æ °Ë»ç
- ¸ÖƼ Æ÷Æ® º¹°°æ °Ë»ç
- ·Îº¿ Áö¿ø ¼ö¼ú
Á¦6Àå º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµ ´ë½Ãº¸µå
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, ¸ÅÃâ
- º´¿ø
- Ŭ¸®´Ð
- ±âŸ
Á¦7Àå º¹°°æÇÏ Ãæ¼öÀýÁ¦¼ú ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м® : Á¦Ç°º°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°
- Áö¿ª ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â :
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï »óȲ
- ±â¾÷/°æÀï ºÐ·ù
- º¥´õ »óȲ
- ÁÖ¿ä ÆÇ¸Å´ë¸®Á¡¡¤Ã¤³Î ÆÄÆ®³Ê ¸®½ºÆ®
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
- Medtronic plc
- Johnson & Johnson
- Stryker Corporation
- Olympus Corporation
- Conmed Corporation
- B. Braun SE
- Richard Wolf GmbH
- Karl Storz SE &Co. KG
ksm 24.11.05
Laparoscopic Appendectomy Market Growth & Trends:
The global laparoscopic appendectomy market size is expected to reach USD 3.41 billion by 2030 and is projected to grow at a CAGR of 5.0%, according to a new report by Grand View Research, Inc.Appendicitis is a prevalent condition, affecting approximately 7.0%-10.0% of the global population. According to a study published by the European Journal of Medical & Health Sciences in July 2024, acute appendicitis (AA) is a leading cause of acute abdominal pain in both adults and children presenting to emergency departments, with about 17.7 million cases annually. The lifetime risk of appendicitis is estimated at 7.0%-8.0%. This high prevalence drives significant demand for effective treatment options, bolstering the market growth. The condition's impact across various age groups reinforces the increasing need for minimally invasive surgical solutions, highlighting the market's expanding role in addressing this widespread medical issue.
The field of laparoscopic surgery witnessed remarkable advancements, which are pivotal in driving market growth. Innovations such as high-definition laparoscopic cameras, improved imaging systems, and robotic-assisted surgical platforms enhance surgical precision and outcomes. For instance, the integration of robotic systems such as the da Vinci Surgical System offers enhanced dexterity and control, leading to better surgical results and shorter recovery times. The development of advanced laparoscopic tools and energy devices has also improved procedural efficiency and patient safety, making laparoscopic appendectomy the preferred choice for many surgeons.
Supportive regulatory frameworks play a crucial role in market expansion. Regulatory bodies such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) ensure the safety and efficacy of laparoscopic devices through rigorous approval processes. Their endorsement of new technologies fosters innovation and market entry, ensuring that healthcare providers have access to the latest advancements in laparoscopic surgery. These regulatory bodies also help streamline the approval process for new devices, accelerating their availability in the market.
Laparoscopic Appendectomy Market Report Highlights:
- Based on product, laparoscopes segment held the largest share of 39.7% in 2023 due to the increasing adoption of minimally invasive surgeries, technological advancements in laparoscopes, and the growing preference for laparoscopic appendectomy over traditional open surgeries.
- Based on technology, the multi-port laparoscopy segment held the largest revenue share of 43.6% in 2023.
- Based on end use, the hospital segment dominated the market, capturing a substantial revenue share of 61.4% in 2023 due to the high patient volume, advanced infrastructure, availability of skilled surgeons, and the comprehensive care that hospitals provide.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Technology
- 2.2.3. End Use
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Laparoscopic Appendectomy Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. High Prevalence of Appendicitis
- 3.2.1.2. Technological Advancements
- 3.2.1.3. Growing Preference for Minimally Invasive Procedures
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Costs of Advanced Technology
- 3.2.2.2. Risk of Complications
- 3.3. Laparoscopic Appendectomy Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Laparoscopic Appendectomy Market: Product Estimates & Trend Analysis
- 4.1. Global Laparoscopic Appendectomy Market: Product Dashboard
- 4.2. Global Laparoscopic Appendectomy Market: Product Movement Analysis
- 4.3. Global Laparoscopic Appendectomy Market by Product, Revenue
- 4.4. Medical Laparoscopic Robots
- 4.4.1. Medical laparoscopic robots market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Laparoscopes
- 4.5.1. Laparoscopes market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Hand Instruments
- 4.6.1. Hand instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Insufflators & Accessories
- 4.7.1. Insufflators & accessories market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Laparoscopic Appendectomy Market: Technology Estimates & Trend Analysis
- 5.1. Global Laparoscopic Appendectomy Market: Technology Dashboard
- 5.2. Global Laparoscopic Appendectomy Market: Technology Movement Analysis
- 5.3. Global Laparoscopic Appendectomy Market Estimates and Forecasts, By Technology, Revenue (USD Million)
- 5.4. Single-Port laparoscopy
- 5.4.1. Single-Port laparoscopy market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Multi-Port laparoscopy
- 5.5.1. Multi-Port laparoscopy market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Robotic-assisted surgery
- 5.6.1. Robotic-assisted surgery market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Laparoscopic Appendectomy Market: End Use Estimates & Trend Analysis
- 6.1. Global Laparoscopic Appendectomy Market: End Use Dashboard
- 6.2. Global Laparoscopic Appendectomy Market: End Use Movement Analysis
- 6.3. Global Laparoscopic Appendectomy Market Estimates and Forecasts, By End Use, Revenue (USD Million)
- 6.4. Hospital
- 6.4.1. Hospital market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Clinics
- 6.5.1. Clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Other
- 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Laparoscopic Appendectomy Market: Regional Estimates & Trend Analysis by Product, Technology, and End Use
- 7.1. Regional Dashboard
- 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework/ reimbursement structure
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Vendor Landscape
- 8.2.1. List of key distributors and channel partners
- 8.2.2. Key company market share analysis, 2023
- 8.2.3. Medtronic plc
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Johnson & Johnson
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Stryker Corporation
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Olympus Corporation
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Conmed Corporation
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. B. Braun SE
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Richard Wolf GmbH
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Karl Storz SE & Co. KG
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives